EXCLUSIVE: Federal prosecutors have pursued a 'massive' probe of off-label marketing of drugs at GlaxoSmithKline, and the indictment of a former associate general counsel is 'just a small piece of it,' according to one of her defense attorneys. | ALSO SEE: It's a Flurry! Ex-Glaxo Lawyer Makes Case for Naming Co-Conspirators
• King & Spalding Twist Turns Case Into Lawyer vs. Lawyer
• Ex-In-House Lawyer for Glaxo Pleads Not Guilty
Font Size: 
Court Docs Detail the Lawyers on Ex-Glaxo In-House Counsel's Team, Show Government Scrutiny of the Company
Corporate Counsel
March 2, 2011
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.
